Vivani Medical (VANI) news
Recent news
Vivani Medical reports second quarter 2026 financial results and provides business update
AInvest Wire · Aug 13, 2026ImportantVivani Medical, Inc.: Vivani Medical menandatangani perjanjian dengan Novo Nordisk bagi menilai NPM-139, implan semaglutide
AInvest Wire · Jul 8, 2026Vivani Medical: No exclusivity provisions for NPM-139, or Vivani's proprietary nanoportal technology associated with agreement with Novo Nordisk
Vivani Medical, Inc. and Novo Nordisk have entered into an agreement to evaluate NPM-139, a miniature, ultra long-acting semaglutide implant for chronic weight management, with no exclusivity provisions applied to NPM-139 or Vivani’s proprietary nanoportal technology under the arrangement,…
AInvest Wire · Jul 7, 2026Vivani Medical, Inc.: Vivani Medical in pact with Novo Nordisk to evaluate NPM-139, a miniature, ultra long-acting semaglutide
Vivani Medical, Inc. (NASDAQ: VANI) has announced a collaboration with Novo Nordisk A/S, the developer of Ozempic® and Wegovy®, to evaluate miniature ultra long-acting semaglutide implant . This partnership follows promising preclinical and early clinical data demonstrating the potential of NPM-139…
AInvest Wire · Jul 7, 2026Vivani announces entry into merger agreement between wholly owned subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
Vivani Medical, Inc. (NASDAQ: VANI) has announced plans to spin off its wholly owned subsidiary, Cortigent, Inc., as an independent publicly traded company, with the intention of listing it on Nasdaq under the ticker symbol “CRGT”. The spin-off is expected to be completed by late 2025, subject to…
AInvest Wire · Jul 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.